Personensuche
Personensuche
Es wurde 1 Person gefunden.
Aktuelle Veranstaltungen
Keine aktuellen Veranstaltungen.
Vergangene Veranstaltungen (max. 10)
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
Quantitative evaluation of ¹²³I-MIBG imaging in patients with myocarditis : Impairment of cardiac neuronal function revisitedIn: Annals of Nuclear Medicine, 2025, in pressDOI (Open Access)
-
[⁶⁸Ga]Ga-FAPI-46 PET accuracy for cancer imaging with histopathology validation : A single-centre, single-arm, interventional, phase 2 trialIn: The Lancet Oncology, Jg. 26, 2025, Nr. 9, S. 1204 – 1214DOI (Open Access)
-
68Ga-Fibroblast Activation Protein Inhibitor PET/CT Improves Detection of Intermediate and Low-Grade Sarcomas and Identifies Candidates for Radiopharmaceutical TherapyIn: Journal of Nuclear Medicine (JNM), Jg. 65, 2024, Nr. 6, S. 880 – 887
-
Delayed ⁶⁸Ga-FAPI-46 PET/MR imaging confirms ongoing fibroblast activation in patients after acute myocardial infarctionIn: International Journal of Cardiology (IJC) Heart & Vasculature, Jg. 50, 2024, 101340DOI (Open Access)
-
Detection of tumour heterogeneity in patients with advanced, metastatic castration-resistant prostate cancer on [⁶⁸Ga]Ga-/[¹⁸F]F-PSMA-11/-1007, [⁶⁸Ga]Ga-FAPI-46 and 2-[¹⁸F]FDG PET/CT : a pilot studyIn: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 52, 2024, Nr. 1, S. 342 – 353DOI (Open Access)
-
Diagnostic Accuracy of ⁶⁸Ga-FAPI Versus ¹⁸F-FDG PET in Patients with Various MalignanciesIn: Journal of Nuclear Medicine (JNM), Jg. 65, 2024, Nr. 3, S. 372 – 378DOI (Open Access)
-
FAPI PET Imaging Supports Clinical Decision Making in Academic Cardiology Practice : A Pictorial Imaging VignetteIn: JACC Cardiovascular Imaging, Jg. 17, 2024, Nr. 7, S. 811 – 823DOI (Open Access)
-
Fibroblast Activation Protein α-Directed Imaging and Therapy of Solitary Fibrous TumorIn: Journal of Nuclear Medicine (JNM), Jg. 65, 2024, Nr. 2, S. 252 – 257DOI (Open Access)
-
Fibroblast Activation Protein-Directed Imaging Outperforms ¹⁸F-FDG PET/CT in Malignant Mesothelioma : A Prospective, Single-Center, Observational TrialIn: Journal of Nuclear Medicine (JNM), Jg. 65, 2024, Nr. 8, S. 1188 – 1193
-
Imaging of Cardiac Fibrosis : How Far Have We Moved From Extracellular to Cellular?In: Seminars in Nuclear Medicine, 2024, in pressDOI (Open Access)
-
The Role of Fibroblast Activation Protein in Glioblastoma and Gliosarcoma : A Comparison of Tissue, ⁶⁸Ga-FAPI-46 PET Data, and Survival DataIn: Journal of Nuclear Medicine (JNM), Jg. 65, 2024, Nr. 8, S. 1217 – 1223
-
[⁶⁸Ga]Ga-FAPI versus 2-[¹⁸F]FDG PET/CT in patients with autoimmune thyroiditis : A case control studyIn: EJNMMI Research, Jg. 14, 2024, Nr. 1, 66DOI, Online Volltext (Open Access)
-
68Ga-FAPI PET/CT Interobserver Agreement on Tumor Assessment : An International Multicenter Prospective StudyIn: Journal of Nuclear Medicine (JNM), Jg. 64, 2023, Nr. 7, S. 1043 – 1048DOI (Open Access)
-
68Ga-Labeled Fibroblast Activation Protein Inhibitor (⁶⁸Ga-FAPI) PET for Pancreatic Adenocarcinoma : Data from the ⁶⁸Ga-FAPI PET Observational TrialIn: Journal of Nuclear Medicine (JNM), Jg. 64, 2023, Nr. 12, S. 1910 – 1917DOI (Open Access)
-
Corneal confocal microscopy identifies corneal nerve loss and increased Langerhans cells in presymptomatic carriers and patients with hereditary transthyretin amyloidosisIn: Journal of Neurology, Jg. 270, 2023, Nr. 7, S. 3483 – 3491DOI (Open Access)
-
Correlation of the apparent diffusion coefficient with the standardized uptake value in meningioma of the skull plane using [68]Ga-DOTATOC PET/MRIIn: Nuclear Medicine Communications, Jg. 44, 2023, Nr. 12, S. 1106 – 1113
-
Fibroblast Activation Protein Inhibitor (FAPI)-PET Imaging in SarcomaIn: PET Clinics, Jg. 18, 2023, Nr. 3, S. 353 – 359
-
Fibroblast Activation Protein Inhibitor Theranostics : The Case for Use in SarcomaIn: PET Clinics, Jg. 18, 2023, Nr. 3, S. 361 – 367
-
Fibroblast-Activation Protein PET and Histopathology in a Single-Center Database of 324 Patients and 21 Tumor EntitiesIn: Journal of Nuclear Medicine (JNM), Jg. 64, 2023, Nr. 5, S. 711 – 716DOI (Open Access)
-
Multi-center study of inter-rater reproducibility, image quality, and diagnostic accuracy of CZT versus conventional SPECT myocardial perfusion imagingIn: Journal of Nuclear Cardiology, Jg. 30, 2023, Nr. 2, S. 528 – 539DOI (Open Access)
-
PET/CT-identified atrial hypermetabolism is an index of atrial inflammation in patients with atrial fibrillationIn: Journal of Nuclear Cardiology, Jg. 30, 2023, Nr. 5, S. 1761 – 1772.
-
Quantitative ⁹⁹mTc-DPD-SPECT/CT assessment of cardiac amyloidosisIn: Journal of Nuclear Cardiology, Jg. 30, 2023, Nr. 1, S. 101 – 111DOI (Open Access)
-
Regression of Myocardial ⁹⁹mTc-DPD Uptake After Tafamidis Treatment of Cardiac Transthyretin AmyloidosisIn: Journal of Nuclear Medicine (JNM), Jg. 64, 2023, Nr. 7, S. 1083 – 1086DOI (Open Access)
-
Superior Tumor Detection for ⁶⁸Ga-FAPI-46 Versus ¹⁸F-FDG PET/CT and Conventional CT in Patients with CholangiocarcinomaIn: Journal of Nuclear Medicine (JNM), Jg. 64, 2023, Nr. 7, S. 1049 – 1055DOI (Open Access)
-
Visualization of fibroblast activation using ⁶⁸Ga-FAPI PET/CT after pulmonary vein isolation with pulsed field compared with cryoballoon ablationIn: Journal of Nuclear Cardiology, Jg. 30, 2023, Nr. 5, S. 2018 – 2028DOI (Open Access)
-
68Ga-FAPI as a Diagnostic Tool in Sarcoma : Data from the 68Ga-FAPI PET Prospective Observational TrialIn: Journal of Nuclear Medicine (JNM), Jg. 63, 2022, Nr. 1, S. 89 – 95DOI (Open Access)
-
A novel TTR mutation (p.Ala65Val) underlying late-onset hereditary transthyretin (ATTRv) amyloidosis with mixed cardiac and neuropathic phenotype : a case reportIn: BMC Neurology, Jg. 22, 2022, Nr. 1, 469DOI, Online Volltext (Open Access)
-
Cardiac fibroblast activation detected by 68Gallium-FAPI-46 positron emission tomography–magnetic resonance imaging as a sign of chronic activity in cardiac sarcoidosisIn: European Heart Journal - Case Reports (EHJ-Case Reports), Jg. 6, 2022, Nr. 1, ytac005DOI (Open Access)
-
Clinical features and predictors of atrial fibrillation in patients with light-chain or transthyretin cardiac amyloidosisIn: ESC Heart Failure, Jg. 9, 2022, Nr. 3, S. 1740 – 1748DOI, Online Volltext (Open Access)
-
Corneal confocal microscopy to detect early immune-mediated small nerve fibre loss in AL amyloidosisIn: Annals of Clinical and Translational Neurology, Jg. 9, 2022, Nr. 6, S. 853 – 863DOI, Online Volltext (Open Access)
-
First experiences with dynamic renal [⁶⁸Ga]Ga-DOTA PET/CT : A comparison to renal scintigraphy and compartmental modelling to non-invasively estimate the glomerular filtration rateIn: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 49, 2022, Nr. 10, S. 3373 – 3386DOI (Open Access)
-
Initial Clinical Experience with ⁹⁰Y-FAPI-46 Radioligand Therapy for Advanced-Stage Solid Tumors : A Case Series of 9 PatientsIn: Journal of Nuclear Medicine (JNM), Jg. 63, 2022, Nr. 5, S. 727 – 734DOI (Open Access)
-
Pitfalls and Common Findings in ⁶⁸Ga-FAPI PET : A Pictorial AnalysisIn: Journal of Nuclear Medicine (JNM), Jg. 63, 2022, Nr. 6, S. 890 – 896DOI (Open Access)
-
Prevalence and predictors of neurological manifestations in systemic AL amyloidosisIn: Journal of the Neurological Sciences, Jg. 440, 2022, 120341
-
Safety and Efficacy of 90Y-FAPI-46 Radioligand Therapy in Patients with Advanced Sarcoma and Other Cancer EntitiesIn: Clinical Cancer Research, Jg. 28, 2022, Nr. 19, S. 4346 – 4353DOI (Open Access)
-
Visualization of thermal damage using ⁶⁸ Ga-FAPI-PET/CT after pulmonary vein isolationIn: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 49, 2022, S. 1553 – 1559DOI (Open Access)
-
⁶⁸Ga]FAPI-PET/CT for radiation therapy planning in biliary tract, pancreatic ductal adeno-, and adenoidcystic carcinomasIn: Scientific Reports, Jg. 12, 2022, Nr. 1, 16261DOI, Online Volltext (Open Access)
-
Cardiac fibroblast activation detected by Ga-68 FAPI PET imaging as a potential novel biomarker of cardiac injury/remodelingIn: Journal of Nuclear Cardiology, Jg. 28, 2021, Nr. 3, S. 812 – 821DOI (Open Access)
-
Complete metabolic response in patients with advanced nonsmall cell lung cancer with prolonged response to immune checkpoint inhibitor therapyIn: Journal for ImmunoTherapy of Cancer, Jg. 9, 2021, Nr. 3, S. 002262DOI, Online Volltext (Open Access)
-
First Experience Using ¹⁸F-Flubrobenguane PET Imaging in Patients with Suspected Pheochromocytoma or ParagangliomaIn: Journal of Nuclear Medicine (JNM), Jg. 62, 2021, Nr. 4, S. 479 – 485DOI (Open Access)
-
Head-to-head intra-individual comparison of biodistribution and tumor uptake of ⁶⁸Ga-FAPI and ¹⁸F-FDG PET/CT in cancer patientsIn: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 48, 2021, Nr. 13, S. 4377 – 4385DOI (Open Access)
-
Imaging Inflammation with Positron Emission TomographyIn: Biomedicines, Jg. 9, 2021, Nr. 2, S. 212DOI, Online Volltext (Open Access)
-
Impact of time to diagnosis on Mayo stages, treatment outcome, and survival in patients with AL amyloidosis and cardiac involvementIn: European Journal of Haematology, Jg. 107, 2021, Nr. 4, S. 449 – 457DOI (Open Access)
-
Predictive Factors for RAI-Refractory Disease and Short Overall Survival in PDTCIn: Cancers, Jg. 13, 2021, Nr. 7, S. 1728DOI, Online Volltext (Open Access)
-
Visualization of Fibroblast Activation After Myocardial Infarction Using 68Ga-FAPI PETIn: Clinical Nuclear Medicine, Jg. 46, 2021, Nr. 10, S. 807 – 813
-
Single Tracer Combined Imaging : The Role of PET/MRI from Research Domain to Clinical ArenaIn: Current Cardiovascular Imaging Reports, Jg. 13, 2020, Nr. 7, 22
-
68Ga-FAPI-46 PET for Imaging of FAP-expressing Cancer : Results from a Prospective, Single-Arm, Interventional Phase 2 Clinical TrialIn: Journal of Nuclear Medicine (JNM). New York: Springer, Jg. 66, 2025, Nr. Supplement 1, 251524Online Volltext (Open Access)
-
Investigation of Cardiac Amyloid Deposits as a Cause of Cardiac Dysfunction in Persons with Alzheimer's Disease : The Prospective CACAO-PET StudyIn: Journal of Nuclear Medicine (JNM). New York: Springer, Jg. 66, 2025, Nr. Supplement 1, 252027Online Volltext (Open Access)
-
The Role Of Fibroblast Activation Protein in Glioblastoma and Gliosarcoma : A Comparison Of Tissue, 68ga-Fapi-46 Positron Emission Tomography and Survival Data
29th Annual Meeting and Education Day of the Society for Neuro-Oncology, November 21-24, 2024, Houston, TX, USA,In: Neuro-Oncology. Oxford: Oxford University Press, Jg. 26, 2024, Nr. Supplement 8, S. viii196 – viii197 -
The Role of Fibroblast Activation Protein in Glioblastoma and Gliosarcoma : A Comparison of Tissue, 68GA-FAPI-46 Positron Emission Tomography and Survival Data
19th Meeting of the European Association of Neuro-Oncology (EANO 2024), October 17-20, 2024, Glasgow, UK,In: Neuro-Oncology. Oxford: Oxford University Press, Jg. 26, 2024, Nr. Supplement 5, S. v25 – v25 -
Fibroblast activation protein alpha (FAPα) directed imaging and radioligand therapy in patients with solitary fibrous tumor (SFT)
55th Annual Conference of the Society of Nuclear Medicine (SNMICON), November 16-19, 2023, Jodhpur, India,In: Journal of Nuclear Medicine (JNM). New York: Springer, Jg. 64, 2023, Nr. Suppl. 1, P714 -
Screening for occult transthyretin amyloidosis in patients with degenerative aortic stenosis and amyloid red-flagsIn: European Journal of Heart Failure. Oxford: Wiley, Jg. 25, 2023, Nr. Suppl. 2, S. 359 – 359
-
68GA-FAPI PET/CT in the evaluation of Non-Small Cell Lung Cancer (NSCLC)
EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine ; October 15-19, 2022, Barcelona, Spain,In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 49, 2022, Nr. Supplement 1, S. S107DOI (Open Access) -
FAPI, PSMA and FDG PET/CT in patients with advanced metastatic castration-resistant prostate cancer (mCRPC) : a triple tracer comparison
EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine October ; 15-19, 2022 Barcelona, Spain,In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 49, 2022, Nr. Supplement 1, S. S118 – S119DOI (Open Access) -
Safety and efficacy of [90Y]Y-FAPI-46 radioligand therapy in patients with advanced sarcomas and other cancer entities
ESMO Congress 2022, 9 - 13 September 2022, Paris, France,In: Annals of Oncology. Amsterdam: Elsevier, Jg. 33, 2022, Nr. Supplement 7: Abstract Book of the ESMO Congress 2022, 9 - 13 September 2022, S. S1231 – S1232DOI (Open Access) -
Superiority of [68Ga]Ga-FAPI-46 over [18F]F-FDG PET/CT for cholangiocarcinoma imaging
EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine ; October 15-19, 2022 Barcelona, Spain,In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 49, 2022, Nr. Supplement 1, S. S192 – S193DOI (Open Access) -
Target Expression and FAP-Directed Tumour Imaging in a Large, Single-Centre PET Database of 324 Patients and 21 Tumour Entities
EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine ; October 15-19, 2022, Barcelona, Spain,In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 49, 2022, Nr. Supplement 1, S. S119 – S120DOI (Open Access) -
A novel theranostic approach for sarcoma : Insights on diagnostic and therapeutic use of FAP-radioligands
Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 01.-04. Oktober 2021, Hybrid-Kongress,In: Oncology Research and Treatment. Basel: Karger, Jg. 44, 2021, Nr. Supplement 2, S. 11 – 12DOI (Open Access) -
Ga-68-FAPI for sarcoma imaging : Data from the FAPI-PET prospective observational trial
2021 SNMMI Annual Meeting, June 11th to June 15th, 2021, virtual,In: Journal of Nuclear Medicine (JNM). New York: Springer, Jg. 62, 2021, Nr. Suppl. 1, 126 -
Increased FDG uptake in AF individuals suggesting atrial inflammation visualized by FDG PET/CT with glucose uptake suppression protocolsIn: European Heart Journal. Oxford: Oxford University Press (OUP), Jg. 42, 2021, Nr. Supplement_1, ehab724.0324DOI (Open Access)
-
Initial clinical experience with [Y-90]Y-FAPI-46 radioligand therapy for advanced stage solid tumors
Annual Congress of the European Association of Nuclear Medicine, October 20-23, 2021, Virtual,In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 48, 2021, Nr. Suppl. 1, S. S290DOI (Open Access) -
Visualization of fibroblast activation after myocardial infarction using 68Ga-FAPI-PETIn: European Heart Journal. Oxford: Oxford University Press (OUP), Jg. 42, 2021, Nr. Supplement_1, ehab724.0255DOI (Open Access)
-
PERCIST-derived metabolic volume response predicts overall and progression-free survival in patients with malignant pleural mesothelioma treated with Pembrolizumab
EANM‘20 ; Annual Congress of the European Association of Nuclear Medicine ; October 22 – 30, 2020, Wien, Virtual,In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 47, 2020, Nr. Supplement 1, S. S353DOI (Open Access) -
PERCIST-derived metabolic volume response predicts overall and progression-free survival in patients with malignant pleural mesothelioma treated with Pembrolizumab
Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging, July 11-14, 2020, Virtual,In: Journal of Nuclear Medicine (JNM). New York: Springer, Jg. 61, 2020, Nr. Suppl. 1, 243Online Volltext (Open Access) -
Volumetric PET response assessment outperforms conventional criteria in patients receiving high-dose pembrolizumab for malignant mesothelioma
ESMO Virtual Congress 2020, 19.-21.09- und 16.-18.10.2020,In: Annals of Oncology. Amsterdam: Elsevier, Jg. 31, 2020, Nr. Suppl. 4, S. S1076 – S1077DOI (Open Access) -
PET/MR : Perfusion and ViabilityIn: Hybrid Cardiac Imaging / Nekolla, Stephan G.; Rischpler, Christoph (Hrsg.). Cham: Springer International Publishing, 2021, S. 231 – 241
-
68Ga-FAPI-46 PET/CT for cancer imaging : Results of a single-center, prospective, interventional, single-arm clinical trial
2025 ASCO Genitourinary Cancers Symposium, February 13-15, 2025, San Francisco, CA, USA,In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 43, 2025, Nr. 5, Supplement, 457 -
68Ga-FAPI PET/CT novel diagnostic tool in sarcoma
Annual Congress of the European Association of Nuclear Medicine, 9-13 September, 2023, Vienna, Austria,In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 50, 2023, Nr. 1 supplement, S. S414 – S415